National Summary Report
Latest data from May 19, 2023
HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.
Health Center COVID-19 Survey Tool Questions
Health Center COVID-19 Survey Tool User Guide
Health Center Program Look-Alike Survey Data for COVID-19
COVID-19 Health Center Survey Interactive Data Dashboards
View cumulative vaccination data nationally; by state, territory, and freely associated state; and among patients identified as racial and/or ethnic minorities. New data views: total vaccinations (all sources) and Health Center Vaccine Program (federal allocations only).
View COVID-19 testing data by race/ethnicity.
Note: The dashboard data are updated bi-weekly using Health Center COVID-19 Survey data.
Number of Health Center respondents = 1027 (75% of all Health Centers)
Data represents information provided by health centers funded through H80 grants from a single, specified bi-weekly reporting date as indicated above. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 74,915 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) |
67.70%
|
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 5,671 |
| Racial and/or Ethnic Minority Patients | 67.08% |
Patients Tested by Race and Ethnicity
| Race/Ethnicity | Patients Tested by race and ethnicity, Virus Detection (PCR, antigen)2 | Patients Tested Positive by race and ethnicity, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 29.66% | 30.59% |
| White, Hispanic/Latino Patients | 29.46% | 27.12% |
| Black/African American, Non-Hispanic/Latino Patients |
12.45% |
16.84% |
| Black/African American, Hispanic/Latino Patients | 1.34% | 2.05% |
| Asian Patients3 | 2.67% | 2.87% |
| American Indian/Alaska Native Patients3 |
2.14% |
1.29% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.15% | 0.72% |
| Patients with More Than One Race3 | 4.88% | 6.08% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 8.08% | 5.36% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.86% | 1.59% |
| Unreported/Refused to Report Race and Ethnicity | 6.30% | 5.48% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 6,500 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 77.67% |
| COVID-19 Immunization Series Completed | 3,990 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 75.44% |
| COVID-19 Immunization Series Additional | 23,956 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 68.34% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 19.91% | 21.88% | 28.50% |
| White, Hispanic/Latino Patients | 28.62% | 28.12% | 23.03% |
| Black/African American, Non-Hispanic/Latino Patients | 14.08% |
12.06% |
11.23% |
| Black/African American, Hispanic/Latino Patients | 1.52% | 1.28% | 0.91% |
| Asian Patients3 | 4.85% |
6.52% |
8.26% |
| American Indian/Alaska Native Patients3 | 1.17% | 1.18% | 2.67% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.35% | 0.98% | 0.82% |
| Patients with More Than One Race3 | 3.63% | 3.41% | 3.79% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 14.03% | 13.66% | 10.82% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.75% | 2.66% | 1.71% |
| Unreported/Refused to Report Race and Ethnicity |
8.09% |
8.27% | 8.27% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 31.06% |
| 1 to 24 Hours | 33.79% |
| More Than 24 Hours | 30.57% |
| N/A | 4.58% |
Operations and Staff
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Community-Based Events (Mobile Vans, Pop-Up Clinics, School-Based Sites, or Family Vaccination Clinics) | 25.02% |
| Number of Community-Based Events | 1,377 |
| Number of Collaboration Community-Based Events | 585 |
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 28.92% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 41.87% |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 234,461 |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask | 14.31% |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 29,270
|
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Percent of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 15.68%
|
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 | 62.94% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 27.69% |
| White, Hispanic/Latino Patients | 33.01% |
| Black/African American, Non-Hispanic/Latino Patients | 8.31% |
| Black/African American, Hispanic/Latino Patients | 0.43% |
| Asian Patients3 | 7.14% |
| American Indian/Alaska Native Patients3 | 1.17% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.28% |
| Patients with More Than One Race3 | 4.90% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.71% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) |
1.70% |
| Unreported/Refused to Report Race and Ethnicity | 7.67% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 3.83% |
| Patients Experiencing Homelessness | 1.49% |
| Patients Who Are Residents of Public Housing | 7.99% |
| Patients with Limited English Proficiency |
23.32% |
| Children Under 18 Years of Age | 2.45% |
Results from States and Territories
Select a measure on the dropdown menu to view by state or territory.
1 The reported number of patients tested does not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.